LU 224332

Drug Profile

LU 224332

Alternative Names: endothelin-1 antagonist; ET-1 antagonist; LU 302872 racemate

Latest Information Update: 29 Apr 2002

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Antihyperlipidaemics; Propionic acids; Pyrimidines
  • Mechanism of Action Endothelin A receptor antagonists; Endothelin B receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Atherosclerosis

Most Recent Events

  • 04 Mar 1999 New profile
  • 04 Mar 1999 Preclinical development for Atherosclerosis in Canada (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top